Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

NCT04758533 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma
Medulloblastoma, Childhood, Recurrent

Interventions

BIOLOGICAL: AloCELYVIR

Sponsor

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Collaborators

[object Object]